@matthewherper @VPrasadMDMPH FWIW here’s a nice review. Process took about a year. Maybe should’ve gone with ODAC the first time? https://t.co/c3x3atvz5F https://t.co/2plcIHXT91
5,122 followers
1,379 followers
Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study https://t.co/vXhAbxtV48
2,061 followers
On the challenges of withdrawing drugs given early/conditional approval - as mentioned by Prof Ralston #rcpeabdn17 https://t.co/dJpw11l431
427 followers
Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study #ResearchRounds https://t.co/dmsooY0XJY